Vaccinex, Inc.
VCNX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,634 | -$20,251 | -$19,815 | -$22,380 |
| Dep. & Amort. | $94 | $119 | $207 | $169 |
| Deferred Tax | $0 | $0 | -$677 | -$876 |
| Stock-Based Comp. | $341 | $474 | $545 | $541 |
| Change in WC | $2,103 | $318 | -$11 | -$3,210 |
| Other Non-Cash | -$90 | $2,106 | $677 | $458 |
| Operating Cash Flow | -$16,186 | -$17,234 | -$19,074 | -$25,298 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$67 | -$99 | -$32 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$22 | -$67 | -$99 | -$32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$76 | -$74 | -$75 | -$8,540 |
| Stock Issued | $7,125 | $12,519 | $17,050 | $32,848 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,731 | $0 | $0 | -$985 |
| Financing Cash Flow | $15,780 | $12,445 | $16,975 | $23,323 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$428 | -$4,856 | -$2,198 | -$2,007 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,535 | $6,391 | $8,589 | $10,596 |
| End Cash | $1,107 | $1,535 | $6,391 | $8,589 |
| Free Cash Flow | -$16,208 | -$17,301 | -$19,173 | -$25,330 |